BioMarin Pharmaceutical (NASDAQ:BMRN)’s share price was down 3% during mid-day trading on Tuesday following insider selling activity, Analyst Ratings.Net reports. The company traded as low as $103.25 and last traded at $104.10, with a volume of 643,750 shares changing hands. The stock had previously closed at $107.28. Specifically, CEO Jean Jacques Bienaime sold 1,000 shares […]
